US cancer biomarker market is anticipated to grow at a CAGR of 11.8% during the forecast period. The US cancer biomarker market in the North American region is dominating due to various factors such as investments in research and development, high healthcare expenditure, presence of key players and rising prevalence of cancer patients.  

The proactiveness of prostate cancer research organizations in the US are contributing to the market growth. Many organizations fund researchers for supporting their study for cancer research and bringing innovative treatments to the market. There are many organizations working in the US that are creating awareness regarding prostate cancer in men. US Too-International, Prostate Cancer Education and Support network and the Prostate cancer research organization are some of the organizations in the category. There are special organizations as well in the US, for instance, Malecare is a cancer support organization offering help and assistance to gay people with prostate cancer and other cancers. These organizations are increasing public knowledge for prostate cancer and educating them regarding the treatments available in the country. Hence, contributing to the US cancer biomarker market.

Visit for Global Cancer Biomarker Market Report at: https://www.omrglobal.com/industry-reports/cancer-biomarkers-market

According to the American Cancer Society in 2017, it was estimated that out of total 600,920 cancer deaths in the US, around 190,500 would be caused by cigarette smoking. In addition, it was estimated by the World Cancer Research Fund that 20% of cancers are caused by f factors such as physical inactivity, excess body weight, excess alcohol consumption and poor nutrition. Cancer is usually developed among older people. According to the American Cancer Society in 2017, 87% of all the cancers in the US were diagnosed in people with age 50 years and above. These cancers are preventable. Moreover, colorectal and cervical cancers can be prevented by screening and by removal of precancerous lesions. Screening also have reduced the mortality rate significantly for the cancers of colon, breast, and lung.

Research Methodology

The market study of the US cancer biomarker market is incorporated by extensive primary and secondary research conducted by the research team at OMR.  Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include

• Financial reports of companies involved in the market.
• Whitepapers, research-papers, and news blogs.
• Company websites and their product catalog.

The report is intended for biotechnology companies, research laboratories, pharmaceutical companies, research institutions, hospitals, and other related companies for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. US Cancer Biomarker Market Research and Analysis by Biomarker Type

2. US Cancer Biomarker Market Research and Analysis by Cancer Type

3. US Cancer Biomarker Market Research and Analysis by Application

4. US Cancer Biomarker Market Research and Analysis by Profiling Technology

The Report Covers

• Comprehensive research methodology of the US Cancer biomarker market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the US Cancer biomarker market.
• Insights about market determinants which are stimulating the US Cancer Biomarker market.
• Detailed and extensive market segments with regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.